We aspire to be the premier research-intensive biopharmaceutical company.
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.
MSD | Home
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Omnicom PR Group NL Consulting, Public Relations and Communications Services | Other 31 May 2022 | | ||
ULTRAMEDIA Public Relations and Communications Services | Other 30 Jun 2022 | | ||
Silicon Republic Technology, Information and Internet | Other 27 Jul 2022 | | ||
CLARA - Cancéropôle Lyon Auvergne Rhône-Alpes biotech, deeptech, Hospitals and Health Care | Other 4 Sep 2020 30 Jul 2022 | | | |
EFPIA - European Federation of Pharmaceutical Industries and Associations biotech, deeptech, Pharmaceutical Manufacturing | Other 31 Jul 2022 | | ||
NetCancer healthtech, E-Learning Providers | Not capitalistic Not partnership Event 21 Dec 2020 31 Aug 2022 | | | |
idigiT - Institute for Digital Transformation in Healthcare GmbH constructiontech, Consulting, healthtech, Business Consulting and Services | Other 12 Sep 2022 | | ||
Elsa Science biotech, deeptech, healthtech, Hospitals and Health Care | Other 23 Sep 2022 | | ||
Civitta Consulting, Business Consulting and Services | Other 26 Sep 2022 | | ||
Debating Europe Online Audio and Video Media | Other 27 Sep 2022 | |